Press release
Investigation announced for Investors in shares of Viewray Inc (NASDAQ: VRAY)
An investigation on behalf of investors in Viewray Inc (NASDAQ: VRAY) shares over potential wrongdoing at Viewray Inc.
Investors who purchased shares of Viewray Inc (NASDAQ: VRAY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Viewray Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.
Oakwood Village, OH based ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously.
On May 2, 2019, ViewRay, Inc. announced financial results for the first quarter ended March 31, 2019. The Company reported a loss of $0.34 per share while analysts were expecting a per share loss of $0.22.
Then, on August 8, 2019, ViewRay, Inc.announced financial results for the second quarter ended June 30, 2019. ViewRay reported a quarterly loss of $0.32 per share versus analyst estimates of a loss of $0.23.
Shares of Viewray Inc (NASDAQ: VRAY) declined from $8.51 per share on August 5, 2019 to as low as $2.76 per share on August 9, 2019.
Those who purchased shares of Viewray Inc (NASDAQ: VRAY), have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Viewray Inc (NASDAQ: VRAY) here
News-ID: 1831692 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Viewray
Intraoperative MRI Market is Booming Worldwide | Major Giants Hyperfine,Esaote,V …
HTF MI just released the Global Intraoperative MRI Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
𝐌𝐚𝐣𝐨𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 profiled in Intraoperative MRI Market are: Siemens Healthineers, GE…
Image Guided Radiation Therapy Market Opportunities 2023-2030 | GE Healthcare, M …
According to HTF Market Intelligence, the Global Image Guided Radiation Therapy market to witness a CAGR of 11.5% during forecast period of 2023-2028. The market is segmented by Global Image Guided Radiation Therapy Market Breakdown by Application (Hospitals, Ambulatory Surgical Centres, Clinics, Retail Pharmacies) by Type (Nonradiation Based Systems, Radiation Based Systems) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Image Guided Radiation Therapy market size…
Treatment Planning Software Market is Booming Worldwide | Accuray Incorporated, …
Latest released the research study on Global Treatment Planning Software Market, offers a detailed overview of the factors influencing the global business scope. Treatment Planning Software Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Treatment Planning Software. The study covers emerging player’s…
Lawsuit filed for Investors in shares of Viewray Inc (NASDAQ: VRAY)
An investor, who purchased NASDAQ: VRAY shares, filed a lawsuit against Viewray Inc over alleged violations of Federal Securities Laws.
Investors who purchased shares of Viewray Inc (NASDAQ: VRAY) have certain options and for certain investors are short and strict deadlines running. Deadline: November 12, 2019. NASDAQ: VRAY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Oakwood Village, OH based ViewRay, Inc. designs, manufactures and markets…
Lawsuit filed for Investors in shares of Viewray Inc (NASDAQ: VRAY)
An investor, who purchased NASDAQ: VRAY shares, filed a lawsuit against Viewray Inc over alleged violations of Federal Securities Laws.
Investors who purchased shares of Viewray Inc (NASDAQ: VRAY) have certain options and for certain investors are short and strict deadlines running. Deadline: November 12, 2019. NASDAQ: VRAY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Oakwood Village, OH based ViewRay, Inc. designs, manufactures and markets…
MRI-guided Radiation Therapy System Market Key Players Insights - ViewRay Inc, E …
MRI-guided Radiation Therapy System Market Insights
Radiation therapy is evolving with new technologies and techniques. Most of these new methods are focused on maximizing the dose to the tumor site and protecting the surrounding tissue. Image guided radiation therapy offers dose distribution accuracy along with real-time treatment effect. CT-guided radiation treatment is one such image-guided radiation therapy system. However, this requires repeated exposure to X-rays, and has a relatively poor contrast…
